Meet our wonderful Sandra, everyone!

Hi, I’m Sandra Fazackerley, Accounts & Administrative Coordinator at LDA Research.

I first joined LDA in November 2022 as a Fieldwork Executive on a temporary three-week contract, helping the team with all things administrative — and here I am, four years later!

Before joining LDA, I spent many years working in Executive Assistant roles, so I brought with me a strong background in high-level administrative support. Since then, my role within the business has grown and developed in many different ways.

Alongside general administrative support, I now help Project and Research Managers with detailed respondent searches, coordinate and maintain the LDA secure database, support the accounts process, and organise team training and events.

One of the things I enjoy most about working at LDA is the variety. No two days are ever the same, and it is a real pleasure to be part of such a supportive team.

I also take pride in knowing that my work — even the behind-the-scenes details — plays a part in LDA’s contribution to positive outcomes in the world of medical research.

Outside of work, I enjoy walking in the countryside around my home, watching all sorts of sport on TV, socialising, and spending time with my partner and family. I also have a real interest in all things Greek, from the history and food to the language – although learning Greek is still very much an ongoing challenge!

In short, my role at LDA brings together the things I enjoy most: supporting people, keeping things organised, helping projects run smoothly, and contributing in my own way to meaningful work in medical research.

Share:

Facebook
X
LinkedIn
WhatsApp

More Blogs from LDA

The Ethics of Asking: Researching Sensitive Health Topics Well

Patient sensitivity is vital to medical market research. We believe an ethical approach to researching sensitive health topics is essential to good quality research. Ensuring a patient receives proper treatment is the baseline of our research and we employ case by case methods to ensure this. Ethical approaches toward patients guarantees better data quality, harm reduction, and patient satisfaction. When

Continue reading »

Rare Disease Networks Perspectives Series – Blog 3 out of 5: Policy, Protection, and Progress: The Regulatory Perspective on Rare Disease Networks

Regulation, by its nature, is cautious. Agencies tasked with protecting public health are not designed to move fast; they are designed to be rigorous. Yet rare diseases have, from the very beginning, placed regulators in an uncomfortable position. The same caution that protects patients from unsafe or ineffective treatments also, if applied without adaptation, denies those same patients access to

Continue reading »

Contact us

Mandatory fields *